FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomas Odergren

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Consciousness

Concepts & Ideas

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Siv Jönsson; Yi-Fang Cheng; Charlotte Edenius; Kennedy R Lees; Tomas Odergren; Mats O Karlsson
Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke.
Brett L Cucchiara; Scott E Kasner; David A Wolk; Patrick D Lyden; Volker Knappertz; Tim Ashwood; Tomas Odergren; Anders Nordlund
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke.
A Richard Green; Tim Ashwood; Tomas Odergren; David M Jackson
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomas Odergren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Siv Jönsson; Yi-Fang Cheng; Charlotte Edenius; Kennedy R Lees; Tomas Odergren; Mats O Karlsson
Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke.
Clinical pharmacokinetics 2005;44(8):863-78.
2004: Brett L Cucchiara; Scott E Kasner; David A Wolk; Patrick D Lyden; Volker Knappertz; Tim Ashwood; Tomas Odergren; Anders Nordlund
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke.
Critical care medicine 2004;32(1):241-5.
2003: A Richard Green; Tim Ashwood; Tomas Odergren; David M Jackson
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
Pharmacology & therapeutics 2003;100(3):195-214.
2003: A Richard Green; Tomas Odergren; Tim Ashwood
Animal models of stroke: do they have value for discovering neuroprotective agents?
Trends in pharmacological sciences 2003;24(8):402-8.
2003: Per-Henrik Zingmark; Marianne Ekblom; Tomas Odergren; Tim Ashwood; Patrick D Lyden; Mats O Karlsson; E Niclas Jonsson
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.
British journal of clinical pharmacology 2003;56(2):173-83.
2003: Brett L Cucchiara; Scott E Kasner; David A Wolk; Patrick D Lyden; Volker Knappertz; Tim Ashwood; Tomas Odergren; Anders Nordlund
Lack of hemispheric dominance for consciousness in acute ischaemic stroke.
Journal of neurology, neurosurgery, and psychiatry 2003;74(7):889-92.
2003: Carina Centerholt; Marianne Ekblom; Tomas Odergren; Olof Borgå; Gabriela Popescu; Karl-Heinz Molz; Andrea Couturier; Angelika Weil
Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.
European journal of clinical pharmacology 2003;59(2):117-22.
2002: Stig Strid; Olof Borgå; Charlotte Edenius; Karl-Gustav Jostell; Tomas Odergren; Angelika Weil
Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
European journal of clinical pharmacology 2002;58(6):409-15.
2002: Patrick D Lyden; Ashfaq Shuaib; K Ng; K Levin; R P Atkinson; A Rajput; Lawrence R Wechsler; Tim Ashwood; Lennart Claesson; Tomas Odergren; E Salazar-Grueso
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.
Stroke; a journal of cerebral circulation 2002;33(1):122-8.
2001: Patrick D Lyden; M Jacoby; J Schim; Gregory Albers; P Mazzeo; Tim Ashwood; Anders Nordlund; Tomas Odergren
The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.
Neurology 2001;57(7):1199-205.
1998: Patrick D Lyden; Tim Ashwood; Lennart Claesson; G H Friday; Tomas Odergren; S Martin-Munley
The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 1998;7(6):435-41.